The Effect of Indigofera tinctoria Extract on Cdk5 Expression and Signs of Inflammation in A Chronic Pain Rat Model
DOI:
https://doi.org/10.29303/jk.v12i4.4569Keywords:
Indigofera tinctoria, Cdk5, analgesic, anti-inflammatoryAbstract
Chronic pain is a challenging case that requires efforts to find effective drugs with minimal side effects. In the last decade, Cdk5 has become a potential target of chronic pain treatment. Indigofera tinctoria is a plant that grows abundantly in Indonesia and has been used for various purposes. This plant is proven to contain indirubin which was proven as a Cdk5 (Cyclin dependent kinases 5) inhibitor. The objective of this research is to analyze the effect of Indigofera tinctoria in a chronic pain model. This research was conducted on 35 rats divided into 5 groups. CFA (Complete Freud’s Adjuvant) solution was injected into the right plantar area to make a chronic pain model. Indigofera tinctoria extract was given orally in 200 mg/KgBW (D1 group), 300 mg/KgBW (D2 group), and 400 mg/KgBW (D3 group) doses. Treatment was given for 7 days after the sign of chronic inflammation were detected (28 days after CFA induction). The analgesic effect was determined by pain latency on the hotplate, while the anti-inflammatory effect was evaluated by measuring the hind paw volume. The Cdk5 expression was detected at the dorsal root ganglia by immunohistochemistry method. The mean pain latency value of the D2 and D3 groups was greater than that of the other groups. The inflammatory sign in the treatment group was smaller and differs significantly from the positive control group. Cdk5 expression was not statistically different, however, the treatment group showed a lower Cdk5 expression. Indigofera extract has potential analgesic, anti-inflammatory, and Cdk5 inhibitory effects.Downloads
Published
2023-12-31
Issue
Section
Articles
License
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.